메뉴 건너뛰기




Volumn 117, Issue 7, 2011, Pages 2080-2081

Self-determinism: AlloBMT for AML

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; HIDDEN MARKOV MODEL; HUMAN; NOTE; PRIORITY JOURNAL;

EID: 79951819517     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-12-325340     Document Type: Note
Times cited : (3)

References (11)
  • 1
    • 79951815193 scopus 로고    scopus 로고
    • A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
    • Kurosawa S, Yamaguchi T, Miyawaki S, et al.A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission. Blood. 2011;117(7):2113-2120.
    • (2011) Blood , vol.117 , Issue.7 , pp. 2113-2120
    • Kurosawa, S.1    Yamaguchi, T.2    Miyawaki, S.3
  • 2
    • 79951817495 scopus 로고    scopus 로고
    • Accessed January 5, 2011
    • Stochastic process. http://en.wikipedia.org/wiki/Stochastic-process. Accessed January 5, 2011.
    • Stochastic Process
  • 5
    • 0029866169 scopus 로고    scopus 로고
    • Allogenic bone marrow transplantation of chemotherapy for patients with acute myeloid leukemia in first complete remission: A decision analysis approach
    • DOI 10.1007/s002770050164
    • Hertenstein B, Heil G, Heimpel H. Allogenic bone marrow transplantation or chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approach. Ann Hematol. 1996;72(4):223-230. (Pubitemid 26125818)
    • (1996) Annals of Hematology , vol.72 , Issue.4 , pp. 223-230
    • Hertenstein, B.1    Heil, G.2    Heimpel, H.3
  • 7
    • 14544299196 scopus 로고    scopus 로고
    • Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: A decision-analytic approach
    • DOI 10.1592/phco.25.3.325.61593
    • Skrepnek GH, Ballard EE. Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005;25(3):325-334. (Pubitemid 40300319)
    • (2005) Pharmacotherapy , vol.25 , Issue.3 , pp. 325-334
    • Skrepnek, G.H.1    Ballard, E.E.2
  • 9
    • 0034657831 scopus 로고    scopus 로고
    • Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: A decision analysis
    • Nietert PJ, Abboud MR, Silverstein MD, Jackson SM. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood. 2000;95(10):3057-3064. (Pubitemid 30321154)
    • (2000) Blood , vol.95 , Issue.10 , pp. 3057-3064
    • Nietert, P.J.1    Abboud, M.R.2    Silverstein, M.D.3    Jackson, S.M.4
  • 10
    • 55949123875 scopus 로고    scopus 로고
    • Dynamic predicting by landmarking as an alternative for multi-state modeling: An application to acute lymphoid leukemia data
    • van Houwelingen HC, Putter H. Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data. Lifetime Data Anal. 2008;14(4):447-463.
    • (2008) Lifetime Data Anal , vol.14 , Issue.4 , pp. 447-463
    • Van Houwelingen, H.C.1    Putter, H.2
  • 11
    • 15044348009 scopus 로고    scopus 로고
    • Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function
    • DOI 10.1111/j.0006-341X.2005.031209.x
    • Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics. 2005;61(1):223-229. (Pubitemid 40380983)
    • (2005) Biometrics , vol.61 , Issue.1 , pp. 223-229
    • Klein, J.P.1    Andersen, P.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.